Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cognition Therapeutics Says 'In The SHINE Study, CT1812 Did Not Achieve Statistical Significance On The First Of The Ordered Secondary Efficacy Endpoints In The Pooled 100mg And 300mg Dose Group Compared To Placebo'

Author: Benzinga Newsdesk | July 29, 2024 07:58am

Posted In: CGTX